Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DP9SF6
|
|||
| Drug Name |
THR-184
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Renal fibrosis [ICD-11: GC01] | Phase 2 | [1] | |
| Company |
Oxurion
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bone morphogenetic protein 7 (BMP7) | Target Info | Agonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01830920) A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI). U.S. National Institutes of Health. | |||
| REF 2 | Perioperative THR-184 and AKI after Cardiac Surgery. J Am Soc Nephrol. 2018 Feb;29(2):670-679. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.